Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
Jolene Skordis;
Nicoli Nattrass;
(2002)
Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
Journal of health economics, 21 (3).
pp. 405-421.
ISSN 0167-6296
DOI: 10.1016/s0167-6296(01)00133-3
It is estimated that each HIV-positive child in South Africa costs the government more in terms of health and welfare expenses than it does to reduce mother-to-child transmission (MTCT) of HIV through the use of antiretroviral regimens (where the mother continues to breast-feed). Programmes to reduce MTCT of HIV/AIDS are, thus, clearly affordable. Using Nevirapine (according to the HIVNET 012 Protocol) saves more lives and [corrected] is more cost-effective than using Zidovudine (CDC 2 weeks regime).
Item Type | Article |
---|---|
Keywords | Adult, Anti-HIV Agents/*economics/therapeutic use, Child Welfare/*economics, Child, Preschool, *Cost of Illness, Cost-Benefit Analysis, Disease Transmission, Vertical/economics/*prevention & control, Female, HIV Infections/drug therapy/*economics/prevention & control/*transmission, Health Care Costs/*statistics & numerical data, Health Policy, Human, Infant, Infant, Newborn, Nevirapine/economics/therapeutic use, Pregnancy, Pregnancy Complications, Infectious/*drug therapy/economics, Quality-Adjusted Life Years, South Africa/epidemiology, Zidovudine/economics/therapeutic use, Adult, Anti-HIV Agents, economics, therapeutic use, Child Welfare, economics, Child, Preschool, Cost of Illness, Cost-Benefit Analysis, Disease Transmission, Vertical, economics, prevention & control, Female, HIV Infections, drug therapy, economics, prevention & control, transmission, Health Care Costs, statistics & numerical data, Health Policy, Humans, Infant, Infant, Newborn, Nevirapine, economics, therapeutic use, Pregnancy, Pregnancy Complications, Infectious, drug therapy, economics, Quality-Adjusted Life Years, South Africa, epidemiology, Zidovudine, economics, therapeutic use |
ISI | 175204800004 |